GGrantIndex
Sort

1,049,261 grants matching t cell

User Driven Project

$15,462,500
Stuart L Schreiber · Broad Institute, Inc. · U54 · FY2012 · HG

Broad Institute Comprehensive Screening Center

$15,462,500
Stuart L Schreiber · Broad Institute, Inc. · U54 · FY2012 · HG

HVTN Laboratory Program

$15,461,760
Margaret Juliana McElrath · Fred Hutchinson Cancer Research Center · U01 · FY2007 · AI

NIH Chemical Genomics Center

$15,437,118
Christopher Austin · National Center For Advancing Translational Sciences · ZIB · FY2012 · TR

The Comprehensive Center for Chemical Probe Discovery and Optimization at Scripps

$15,404,535
Hugh Rosen · Scripps Research Institute, The · U54 · FY2010 · MH

COG NCTN Network Group Operations Center

$15,368,398
Douglas S. Hawkins · Public Health Institute · U10 · FY2023 · CA

Burnham Center for Chemical Genomics

$15,280,302
John C Reed · Sanford Burnham Prebys Medical Discovery Institute · U54 · FY2008 · HG

Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research

$15,244,065
Mary Custer · Division Of Basic Sciences - Nci · ZIG · FY2021 · CA

Broad Institute Comprehensive Screening Center

$15,241,615
Stuart L Schreiber · Broad Institute, Inc. · U54 · FY2011 · HG

IGF::OT::IGF Human Tumor Atlas Pilot Program

$15,241,462
Rachana Agarwal · Leidos Biomedical Research, Inc. · N01 · FY2017 · CA

INDUSTRIAL PROCESSES REQUIRE CONTINUOUS HEAT AND POWER THAT, CURRENTLY, ONLY FOSSIL FUELS CAN PROVIDE RELIABLY AND COST-EFFECTIVELY, MAKING THE INDUSTRIAL SECTOR THE LARGEST SOURCE OF GREENHOUSE GAS EMISSIONS IN THE US. THE RAPID GROWTH OF WIND AND SOLAR ENERGY HAS CREATED AN UNPRECEDENTED OPPORTUNITY TO REPLACE FOSSIL FUELS WITH LOW- OR ZERO-EMISSIONS POWER, BUT INTERMITTENT GENERATION HAS LIMITED DEPLOYMENT AS A PRIMARY SOURCE OF INDUSTRIAL POWER. ANTORA ENERGY IS ADDRESSING THIS CHALLENGE BY TURNING EXCESS RENEWABLE GENERATION INTO RELIABLE, ON-DEMAND HEAT AND POWER FOR INDUSTRIAL FACILITIES. ANTORA’S COMBINED HEAT AND POWER (CHP) THERMAL BATTERY IS CHARGED WITH RENEWABLE POWER AND CAN DISCHARGE BOTH HEAT AND ELECTRICITY, THE LATTER VIA A SOLID-STATE HEAT ENGINE (SSHE) COMPOSED OF THERMOPHOTOVOLTAIC (TPV) CELLS. THE TPV CELL IS MANUFACTURED USING AN EXPENSIVE SEMICONDUCTOR WAFER THAT DOMINATES THE OVERALL SYSTEM COST. RECENTLY, ANTORA DEMONSTRATED A NEW TPV MANUFACTURING METHOD THAT ENABLES DRAMATICALLY LOWER OVERALL COSTS. IN SCALE-UP, ANTORA PROPOSES SCALING THIS LOW-COST TPV AND SSHE MANUFACTURING TO A 10 MW/YEAR PRE-COMMERCIAL PILOT LEVEL, UNLOCKING THE INVESTMENT NEEDED FOR FULL COMMERCIAL-SCALE PRODUCTION. TO ACHIEVE THIS GOAL, ANTORA WILL (1) VERTICALLY INTEGRATE MANUFACTURING PROCESSES AND TOOLS; (2) PRODUCTIZE TPV INTO AN INTEGRATED SSHE; (3) VERIFY SSHE AND TPV COST AND PERFORMANCE METRICS; AND (4) DEVELOP A TECHNO-ECONOMIC MODEL AND MARKET ANALYSIS WITH INPUT FROM KEY COMMERCIALIZATION PARTNERS. IF SUCCESSFUL, ANTORA WILL ENABLE RAPID DECARBONIZATION IN THE INDUSTRIAL SECTOR (>225 GW), BOLSTER US ENERGY INDEPENDENCE AND SECURITY, AND CREATE HIGH-PAYING JOBS IN THE DOMESTIC ENERGY AND MANUFACTURING SECTORS.

$15,221,496
Antora Energy, Inc. · · FY2025 · Department of Energy

Studies to Evaluate the Toxic Carcinogenic Potential of Test Agents

$15,176,338
Jeffery Dill · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2010 · ES

COG NCTN Network Group Operations Center Year 11 Extension

$15,151,031
Douglas S. Hawkins · Public Health Institute · U10 · FY2025 · CA

The Comprehensive Center for Chemical Probe Discovery and Optimization at Scripps

$15,139,831
Hugh Rosen · Scripps Research Institute, The · U54 · FY2009 · MH

Access for All in ALS (ALL ALS) East Clinical Coordinating Center

$15,032,251
James Dale Berry · Massachusetts General Hospital · OT2 · FY2024 · NS

Monoclonal Antibody-Based Therapeutics for Botulism

$15,013,143
Milan Tomic · Xoma Corporation · N01 · FY2012 · AI

Revision to the Coordinating Center for Type 1 Diabetes TrialNet

$15,000,000
Jeffrey P Krischer · University Of South Florida · U01 · FY2022 · DK

The Human Islet Distribution Coordinating Center (UC4)

$15,000,000
Joyce Carol Niland · Beckman Research Institute/City Of Hope · UC4 · FY2012 · DK

University of Colorado Systems Biotechnology Building

$15,000,000
Thomas R Cech · University Of Colorado · C06 · FY2010 · RR

CoVPN 3004 - A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine Lab

$14,980,054
Margaret Juliana McElrath · Fred Hutchinson Cancer Research Center · UM1 · FY2021 · AI

MRSEC: MRSEC on Nanostructured Interfaces

$14,974,150
Juan J De Pablo · University Of Wisconsin-Madison · · FY2005 · MPS

Study of Muscle, Mobility and Aging: SOMMA2

$14,954,746
Steven R Cummings · California Pacific Med Ctr Res Institute · R01 · FY2025 · AG

Cell Biology Research Improvements and Renovations

$14,954,444
John G. Fitz · Ut Southwestern Medical Center · C06 · FY2010 · RR

An Atlas of Human Brain Cell Variation

$14,907,240
Steven Andrew McCarroll · Broad Institute, Inc. · UM1 · FY2022 · MH

A MultiDisciplinary Cancer Research Facility at Purdue University

$14,902,414
Richard J. Kuhn · Purdue University · C06 · FY2010 · RR